$20 million gift focuses UCSF on depression, mood disorders
A $20 million gift from a longtime UCSF benefactor will help researchers zero in on brain circuitry that sets off mood disorders, such as depression and anxiety, and target personalized treatments. The donation — the second gift of this size from the Ray and Dagmar Dolby Family Fund — will establish the UCSF Dolby Center for Mood Disorders to identify brain-imaging biomarkers that could be targeted for individualized deep-brain stimulation or other treatments. What’s more, the money w ill… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 18, 2018 Category: American Health Authors: Ron Leuty Source Type: news

Toward Adaptive Deep Brain Stimulation for Dystonia Toward Adaptive Deep Brain Stimulation for Dystonia
Can neural oscillations serve as potential biomarkers that might be used as feedback signals for controlling adaptive deep brain stimulation in patients with dystonia?Neurosurgical Focus (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 14, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Depression Treatment: Where We Are Missing the Mark
Depression affects 450 million people worldwide and 15 million adults in the United States (U.S.) alone. Suicide is the 10th leading cause of death in the United States, claiming over 40,000 lives every year. We see these heartbreaking stories making headlines too often, and there are tens of thousands more we do not know about. The scariest part? There is no end in sight. Antidepressants are one of the three most commonly used therapeutic drug classes in the United States. Approximately 1 in 9 Americans of all ages reported taking at least one antidepressant medication — a number that was less than 1 in 50 just th...
Source: Psych Central - September 7, 2018 Category: Psychiatry Authors: Sachin Mehta, M.D. Tags: Antidepressants Bipolar Depression Medications Mood Stabilizers Neuroscience Suicide Treatment Deep brain stimulation Deep transcranial magnetic stimulation Depression Treatment Electroconvulsive Therapy Major Depressive Disorder Source Type: news

Approaches to Closed-loop DBS for Movement Disorders Approaches to Closed-loop DBS for Movement Disorders
This paper summarizes investigational approaches to closed-loop systems of deep brain stimulation for treatment of movement disorders. Which approaches hold most promise?Neurosurgical Focus (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 7, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Deep brain stimulation for the treatment of disorders of consciousness and cognition in traumatic brain injury patients: a review - Kundu B, Brock AA, Englot DJ, Butson CR, Rolston JD.
Traumatic brain injury (TBI) is a looming epidemic, growing most rapidly in the elderly population. Some of the most devastating sequelae of TBI are related to depressed levels of consciousness (e.g., coma, minimally conscious state) or deficits in executi... (Source: SafetyLit)
Source: SafetyLit - August 3, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Abbott wins FDA MR-conditional labeling for Infinity DBS
Abbott (NYSE:ABT) said today it won expanded FDA approval for magnetic resonance conditional labeling for its Infinity Deep Brain Stimulation system designed to treat individuals with Parkinson’s disease and essential tremors. The update will be delivered through an over-the-air software upgrade to all currently implanted Infinity DBS systems, the company said. Abbott touted that with the approval, the Infinity DBS is the first and only FDA-approved MR-conditional directional DBS system. “With this software upgrade, Abbott delivers on a promise to develop powerful features that strengthen the Infinity...
Source: Mass Device - August 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neurological Neuromodulation/Neurostimulation Regulatory/Compliance Abbott Source Type: news

Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling
- FDA approval of new software upgrade for Abbott's deep brain stimulation therapy enables advanced, patient-centric features for people living with Parkinson's disease and essential tremor (Source: Abbott.com)
Source: Abbott.com - August 2, 2018 Category: Pharmaceuticals Source Type: news

High-Tech Parkinson's Therapy With A Powerful Consumer Touch
Smartphone technology combined with deep brain stimulation may offer a life-changing option for people with Parkinson's Disease. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 27, 2018 Category: Pharmaceuticals Authors: John Nosta, Contributor Source Type: news

Is Abbott Losing Share in Key Medtech Markets?
By and large, Abbott Laboratories had a phenomenal second quarter this year – and investors took notice. The company's stock hit its highest point since 1995 on Wednesday after beating Wall Street's quarterly expectations and raising its own outlook for 2018. Abbott, MD+DI's 2017 Medtech Company of the Year, clearly has a lot to celebrate as it continues to show the world what its made of. But at least one medtech analyst noticed that the company appears to have lost market share in cardiac rhythm management (CRM) and neuromodulation. Abbott reported CRM sales of $543 million in the second quarter, representing ...
Source: MDDI - July 18, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Cardiovascular Source Type: news

Medical News Today: Deep brain stimulation 'slows Parkinson's progression'
A recently published study finds that deep brain stimulation, used in early-stage Parkinson's disease, could slow the progression of tremor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 30, 2018 Category: Consumer Health News Tags: Parkinson's Disease Source Type: news

Deep brain stimulation 'slows Parkinson's progression'
A recently published study finds that deep brain stimulation, used in early-stage Parkinson's disease, could slow the progression of tremor. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - June 30, 2018 Category: Neurology Tags: Parkinson's Disease Source Type: news

DBS treatment may slow the progression of Parkinson's tremor in early-stage patients
(Vanderbilt University Medical Center) Deep brain stimulation (DBS) may slow the progression of tremor for early-stage Parkinson's disease patients, according to a Vanderbilt University Medical Center study released in the June 29 online issue of Neurology ® , the medical journal of the American Academy of Neurology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 29, 2018 Category: International Medicine & Public Health Source Type: news

UCLA global health program aims to boost neurological care in South Africa
When it came to getting the best treatment for his parents ’ neurologic illnesses, Sam Miller and his family experienced frustration finding the right doctors in their home country of South Africa.Miller ’s mother, Brenda, developed multiple sclerosis in her late 20s, and his father, Winston, was diagnosed with Parkinson’s disease in his 60s.Over the four decades of his mother ’s illness before her death in 2008, the increasingly acute shortage of neurologists in South Africa made the top specialists there much sought-after and overworked. They had little time to talk through treatment options, much...
Source: UCLA Newsroom: Health Sciences - June 26, 2018 Category: Universities & Medical Training Source Type: news

Medtronic wins expanded FDA indications for Kyphon HV-R bone cement
Medtronic (NYSE:MDT) said yesterday it won expanded FDA 510(k) clearance for its Kyphon HV-R bone cement designed for the fixation of pathological fractures of the sacral vertebral body. The Fridley, Minn.-based company’s Kyphon HV-R bone cement is now indicated for treating pathological fractures of the vertebral body due to osteoporosis, cancer or benign lesions using a cementoplasty procedure. The cement is also indicated for the fixation of pathological fractures of the sacral vertebral body or ala using sacral vertebroplasty or sacroplasty, the company said. “Patients who experience sacral insuff...
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Orthopedics Regulatory/Compliance Spinal Medtronic Source Type: news

Long-term DBS Linked to Less Psychosis, Falls in Parkinson's Long-term DBS Linked to Less Psychosis, Falls in Parkinson's
Ten-year follow-up of patients with Parkinson's disease who underwent subthalamic deep-brain stimulation (DBS) shows they had lower risk for psychosis and falls than those not receiving DBS.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 21, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Deep brain stimulation promising for mild Alzheimer's patients older than 65
Alzheimer's patients older than 65 benefit the most benefit from deep brain stimulation, according to findings from a recent phase II clinical trial. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 19, 2018 Category: Consumer Health News Source Type: news

Deep Brain Stimulation showing promise for patients with mild Alzheimer's disease over 65
(University Health Network) An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix (DBS-f), as observed in the data from the phase 2 findings (12 - 24 months) of the Phase II trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2018 Category: International Medicine & Public Health Source Type: news

Medtronic's deep brain stimulation programmer and app get the FDA nod
Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. (Source: mobihealthnews)
Source: mobihealthnews - June 18, 2018 Category: Information Technology Source Type: news

Medtronic wins FDA nod for DBS clinician programmer
Medtronic (NYSE:MDT) said today it won FDA approval for its Deep Brain Stimulation clinician programmer and Activa programming application. The Fridley, Minn.-based medtech giant said that the Activa programming application, which is designed for use with Samsung Galaxy Tab S2 tablets, is intended to streamline workflows and improve clinician programming for its Activa DBS system. Medtronic said that the programmer will enable upgrades to Activa rechargeable implantable neurostims that will extend their lifespans to 15 years, giving patients an additional six years before they need device replacement. The newly c...
Source: Mass Device - June 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neurological Neuromodulation/Neurostimulation Regulatory/Compliance Medtronic Source Type: news

Adaptive Deep-Brain Stimulation Promising for Parkinson's Adaptive Deep-Brain Stimulation Promising for Parkinson's
Researchers test a DBS device in development that automatically senses and adjusts delivery of electrical stimulation, aiming to avoid dyskinesia and other side effects of current technology.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 12, 2018 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Treatment Advances Give Hope to People with Brain Metastases
Treatment TermsMetastatic Brain and Spine Tumors Author Erin Hull Overview Lisa VanTress didn ’t know why she couldn’t regain her land legs after a 13-hour fishing trip in the summer of 2016. When the dizziness caused her to stumble and fall, she went to the emergency room. She soon learned she had lung cancer that had spread to her brain. Hero Imagebrainmets1932x862.jpg Preview Image Content Blocks CTA Header Learn More CTA ButtonBrain and Spine Metastases Patient Name Lisa VanTress Patient Photo Featured Doctors Peter E. Fecci, MD, PhD Jeffrey Melson Clarke, MD Scott R. Floyd, MD, PhD Relate...
Source: dukehealth.org: Duke Health News - June 8, 2018 Category: Consumer Health News Authors: efh7 at duke.edu Source Type: news

Adaptive deep brain stimulation for Parkinson ’s disease
Researchers designed a self-tuning deep-brain stimulation device and tested it in two patients with Parkinson ’s disease. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - June 5, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Parkinson's: 'Adaptive' brain implant may improve therapy
Deep brain stimulation is used to improve the symptoms of Parkinson's disease, but it has many limitations. Can an innovative implant avoid the drawbacks? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 2, 2018 Category: Consumer Health News Tags: Parkinson's Disease Source Type: news

Parkinson's: 'Adaptive' brain implant may improve therapy
Deep brain stimulation is used to improve the symptoms of Parkinson's disease, but it has many limitations. Can an innovative implant avoid the drawbacks? (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - June 2, 2018 Category: Neurology Tags: Parkinson's Disease Source Type: news

Deep brain stimulation in a rat model of post-traumatic stress disorder modifies forebrain neuronal activity and serum corticosterone - Hashtjini MM, Jahromi GP, Sadr SS, Meftahi GH, Hatef B, Javidnazar D.
OBJECTIVES: Post-traumatic stress disorder (PTSD), one of the most devastating kinds of anxiety disorders, is the consequence of a traumatic event followed by intense fear. In rats with contextual fear conditioning (CFC), a model of PTSD caused by CFC (ele... (Source: SafetyLit)
Source: SafetyLit - May 30, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Self-tuning brain implant could help treat patients with Parkinson ’s disease
NIH BRAIN Initiative-funded research a key first step to improving deep brain stimulation. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 29, 2018 Category: American Health Source Type: news

Self-tuning brain implant could help treat patients with Parkinson's disease
This study describes the first fully implanted DBS system that uses feedback from the brain itself to fine-tune its signaling. The study was supported by the National Institutes of Health's Brain Research through Advancing Innovative Technologies (BRAIN) Initiative and the National Institute of Neurological Disorders and Stroke (NINDS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 29, 2018 Category: International Medicine & Public Health Source Type: news

Deep brain stimulation may offer treatment for type 2 diabetes, study suggests
A surprising (but welcome) side effect of a therapy for obsessive-compulsive disorder may pave the way for a new approach to treating type 2 diabetes — and offer new insights into the links between obesity and the metabolic disease that afflicts close to 1 in 10 American adults.The therapy in... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - May 26, 2018 Category: Science Authors: Melissa Healy Source Type: news

Neuromodulation Continues to be Activity Hotbed
The Neuromodulation market is rapidly growing and has become host to many medtech companies. StimGuard is the latest firm to make significant moves in the space, as it has received CE mark for a wireless neuromodulation device to treat chronic symptoms of overactive bladder. The Pompano Beach, Fla.-based company said its StimGuard would be available in Europe in the summer of 2018. “A wireless system that enables urologists to inject such a clinically proven therapy represents a shift in the field where there has only been one option for over 15 years,” Karl-Dietrich Sievert MD, PhD, professor and co-chairman o...
Source: MDDI - May 18, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news

As a Buddhist Priest, Duke Neurosurgeon Finds Deeper Connection with Patients
Treatment TermsNeurosurgery Author Bryan Roth Overview Dr. Patrick Codd, MD, a Duke neurosurgeon, has been practicing Zen for two decades. The practice, he says, allows him to reflect on his work and relationships with patients and, ultimately, to deliver better care. Content Blocks Preview Image Featured Doctors and Providers Patrick J. Codd, MD Related Blog Posts 5 Minutes with Duke Neurosurgeon Oren Gottfried, MD Robot Reduces Need for Open Brain Surgery to Map Epileptic Seizures Deep brain stimulation surgery while asleep brings relief from dystonia BodyDisplay in Announcement Section:  Archived (Sou...
Source: dukehealth.org: Duke Health News - May 16, 2018 Category: Consumer Health News Authors: efh7 at duke.edu Source Type: news

INTREPID: New DBS System for Parkinson's Meets Endpoints INTREPID: New DBS System for Parkinson's Meets Endpoints
A new multiple-source system for deep-brain stimulation in patients with Parkinson's disease proved effective in the randomized, double-blind INTREPID trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 15, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Deep Brain Stimulation Affects the Activity of Hundreds of Genes
Changes in gene activity levels after DBS appear to underlie improvements seen in a mouse model of Rett syndrome, a genetic disease that causes intellectual disability. (Source: The Scientist)
Source: The Scientist - May 14, 2018 Category: Science Tags: Daily News,The Scientist Source Type: news

Report: Doctors warn that lightning can affect deep brain stimulation devices
Deep brain stimulation devices, used to treat neurological movement disorders like Parkinson’s disease, are vulnerable to strong electromagnetic fields that are created by other electrical devices. But when a 66-year-old Slovenian woman’s DBS implant stopped working, it wasn’t due to interference from a device – the malfunction was caused by lightning. In a case report published this week in the Journal of Neurosurgery, doctors described a unique case they encountered with a patient using a rechargeable DBS system to treat her neck dystonia. When her apartment was struck by lightning, the patie...
Source: Mass Device - May 4, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Neurological Source Type: news

Lightning Can Affect Deep Brain Stimulation Devices
THURSDAY, May 3, 2018 -- Lightning, which can result in strong electromagnetic fields (EMFs), can interfere with deep brain stimulation (DBS) devices, according to a case report published online May 1 in the Journal of Neurosurgery. Noting that DBS... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2018 Category: Pharmaceuticals Source Type: news

FDA Clears Deep-Brain Stimulation Device for Resistant Epilepsy FDA Clears Deep-Brain Stimulation Device for Resistant Epilepsy
The FDA has granted premarket approval for Medtronic's deep-brain stimulation therapy as adjunctive treatment for seizure reduction in adults with refractory epilepsy, the company announced.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 1, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news

Medtronic wins FDA PMA for DBS epilepsy treatment
Medtronic (NYSE:MDT) said today it won FDA premarket approval for its Deep Brain Stimulation therapy, indicated as an adjunctive treatment for reducing the frequency of partial-onset seizures. The DBS treatment is cleared for patients 18 years or older who are refractory or drug resistant to three or more antiepileptic medications, the Fridley, Minn.-based company said. Medtronic’s DBS therapy functions through the delivery of controlled electrical pulses to the anterior nucleus of the thalamus which is part of a network involved in seizures, the company said. Approval came based on seven years of data from the ...
Source: Mass Device - May 1, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neurological Neuromodulation/Neurostimulation Pre-Market Approval (PMA) Regulatory/Compliance Medtronic Source Type: news

Lightning carries potential danger to people with deep brain stimulators
(Journal of Neurosurgery Publishing Group) Patients receiving deep brain stimulation are warned that their neurostimulators may dysfunction when confronted by electromagnetic fields generated by particular electrical devices found at work, home, and in the hospital. A new and potentially dangerous source of dysfunction has been identified: nearby lightening. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 1, 2018 Category: Biology Source Type: news

Unilateral DBS Reduces Axial Essential Tremor Unilateral DBS Reduces Axial Essential Tremor
With greater potential for side effects associated with bilateral deep-brain stimulation, does starting with a unilateral procedure make sense for treating axial essential tremor?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 27, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Boston Sci Sees Strong Data From Parkinson & #039;s Treatment Study
This study meets a new level of rigor in evaluating the effectiveness of a DBS system," Jerrold Vitek, MD, Phd, McKnight professor and chair, Department of Neurology, University of Minnesota Medical School and coordinating principal investigator for the INTREPID study, said in a release. "The double-blind design gives us confidence that the improvements in patients on time with good symptom control, as evaluated by the diary data, are an objective measure of the outcomes and suggests patients will benefit from the Vercise System." Boston Scientific received FDA approval for Vercise late last year. The device...
Source: MDDI - April 24, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news

Boston Scientific touts 1-year data on Vercise DBS in Parkinson ’ s
This study meets a new level of rigor in evaluating the effectiveness of a DBS system,” coordinating principal investigator Dr. Jerrold Vitek, of the University of Minnesota Medical School, said in prepared remarks. “The double-blind design gives us confidence that the improvements in patients on time with good symptom control, as evaluated by the diary data, are an objective measure of the outcomes and suggests patients will benefit from the Vercise System.” Vercise won CE Mark approval in the European Union to treat essential tremor in 2014. FDA approval to treat Parkinson’s followed las...
Source: Mass Device - April 24, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Neuromodulation/Neurostimulation Boston Scientific Parkinson's disease Source Type: news

Boston Scientific Announces Positive Late-Breaking Data From The INTREPID Study
MARLBOROUGH, Mass., April 24, 2018 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced one-year data from the INTREPID study, the first and only prospective, double-blind, randomized, sham-controlled, mul... Devices, Neurology Boston Scientific, INTREPID study, deep brain stimulation, Parkinson's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news

The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study - Nuic D, Vinti M, Karachi C, Foulon P, Van Hamme A, Welter ML.
BACKGROUND: Freezing of gait and falls represent a major burden in patients with advanced forms of Parkinson's disease (PD). These axial motor signs are not fully alleviated by drug treatment or deep-brain stimulation. Recently, virtual reality has emerged... (Source: SafetyLit)
Source: SafetyLit - April 16, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Could BioSig Play a Vital Role in the Bioelectronics Market?
BioSig Technologies is hoping to make an impact in the $4.6 billion electrophysiology (EP) market with its first product offering. The Santa Monica, CA-based company is developing the Pure EP system, a surface electrocardiogram and intracardiac multichannel device. BioSig filed said it filed for FDA clearance of the Pure EP system in late March. Once the company receives FDA clearance then it would turn its attention toward gaining regulatory clearance in Europe. “We feel like we’ve made a very robust submission to FDA,” Ken Londoner, founder and CEO of BioSig, told MD+DI. The Pure EP Syste...
Source: MDDI - April 6, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news

Neuroscientists develop potential tools for the study of brain function
(University of Missouri-Columbia) A team of University of Missouri neuroscientists are inching closer to developing the tools needed to decipher the brain. Now, the team has published a new paper that demonstrates how these proteins can be used as tools to regulate the activity of individual neurons in the brain through changes in temperature. These tools will advance fundamental brain research and potentially lead to 'deep brain stimulation' treatments used for Alzheimer's and Parkinson's patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 21, 2018 Category: International Medicine & Public Health Source Type: news

Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics
Optogenetics has revolutionized the experimental interrogation of neural circuits and holds promise for the treatment of neurological disorders. It is limited, however, because visible light cannot penetrate deep inside brain tissue. Upconversion nanoparticles (UCNPs) absorb tissue-penetrating near-infrared (NIR) light and emit wavelength-specific visible light. Here, we demonstrate that molecularly tailored UCNPs can serve as optogenetic actuators of transcranial NIR light to stimulate deep brain neurons. Transcranial NIR UCNP-mediated optogenetics evoked dopamine release from genetically tagged neurons in the ventral teg...
Source: ScienceNOW - February 8, 2018 Category: Science Authors: Chen, S., Weitemier, A. Z., Zeng, X., He, L., Wang, X., Tao, Y., Huang, A. J. Y., Hashimotodani, Y., Kano, M., Iwasaki, H., Parajuli, L. K., Okabe, S., Teh, D. B. L., All, A. H., Tsutsui-Kimura, I., Tanaka, K. F., Liu, X., McHugh, T. J. Tags: Materials Science, Neuroscience reports Source Type: news

Deep brain stimulation -- A new treatment approach in patients with multiple sclerosis
(Charit é - Universit ä tsmedizin Berlin) A pilot study conducted by researchers from Charit é 's NeuroCure Cluster of Excellence has shown that treatment with deep transcranial magnetic stimulation (dTMS) significantly reduces symptoms of fatigue in patients with multiple sclerosis (MS). Published in the current issue of the journal Neurology: Neuroimmunology& Neuroinflammation*, results from this research suggest that TMS is a safe option for the treatment of patients with MS. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 7, 2018 Category: International Medicine & Public Health Source Type: news

Deep Brain Stimulation May Slow Alzheimer's Deep Brain Stimulation May Slow Alzheimer's
Research into DBS for Alzheimer's has focused on brain regions involved in memory. A new study shows using it in frontal behavioral and cognitive neural networks may slow decline in executive function.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 6, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Asleep Deep Brain Stimulation as Effective as Awake Asleep Deep Brain Stimulation as Effective as Awake
Medscape speaks with the authors of a recent study in Parkinson disease, whose results may lead more patients to seek out this effective but underused therapy.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 5, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Expert Interview Source Type: news

Deep Brain Stimulation May Be Promising Alzheimer ’ s Treatment
DBS at ventral capsule/ventral striatum linked to less decline on Clinical Dementia Rating - Sum of Boxes (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - February 1, 2018 Category: Psychiatry Tags: Neurology, Psychiatry, Journal, Source Type: news